FDA Approves AZATHIOPRINE — Rising Pharma Holdings, Inc.

Rising Pharma Holdings, Inc. announced the approval of a 500 mg oral azathioprine tablet (ANDA075568), offering a generic alternative to the brand formulation approved in 1999. The move leverages the drug’s established market presence, potentially solidifying Rising Pharma’s position in the underserved immunosuppressant space and providing additional fillers to the generic supply chain.